3 September 2024 - On 2 September 2024, the MHRA approved an adapted Moderna COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 sub-variant. 

This vaccine is licensed for adults and children aged 6 months and older.

Read UK Government press release